Acomplia (generic name Rimonabant), is a newly-generated oral medication used to fight obesity. It works by blocking the CB-1 receptors contained in the endocannabinoid system, allowing you not to experience the constant hunger signals, otherwise referred to as "the munchies". Acomplia has also been known to help some quit smoking through the same process.
Currently, it is being used around the world for many different reasons, all coming down to the problem of weight loss. It has been known to help those taking it to lose weight without exercising, as well as improving your cardiovascular health, increasing your good cholesterol while decreasing the bad cholesterol, and reducing fat in your abdominal area. In clinical trials, Acomplia has not only shown that it can assist in weight loss, but also to improve a wide spectrum of cardiometabolic risk factors associated with obesity, as well as aiding in the promotion of sustained weight loss.
Acomplia has just been approved in the European Union for weight loss, and is getting results for people who had all but given up on their hopes for a slimmer body. The side effects of taking Acomplia regularly are slight, and include vomiting and nausea. In very rare cases, Acomplia has caused anxiety, psychosis and depression, but these are not considered to be regular adverse effects from taking the drug. Be sure to ask your doctor about any drug before taking it, as your doctor knows for sure which drugs and dosage would be right for you.
